Biologics Contract Manufacturing Market to Reach US$ 47.3 Bn by 2029
The Global Biologics Contract Manufacturing Market exhibits comprehensive information that is a valuable source of insightful data for business strategists during the decade 2023-2029. This intelligence reports include an investigation based on Current scenarios, Historical records, and Future predictions. The report contains different market predications Related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.
The global market is thus likely to show high growth over the coming years at a CAGR of 8.6% and reach a global market size of US$ 42.1 Bn by 2029.
Get the PDF Sample Copy (Including FULL TOC, Graphs, and Tables) of this report @
Biologics Contract Manufacturing Market Main Competitive Landscape:
Wuxi Biologics, Abzena Ltd., Lonza Group AG ,FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim GmbH, Lonza, SamsungBiologics, Abbvie, Catalent, Bioreliance, Thermo Fischer (Patheon), Eurofins CDMO and others.
Industry News:
For instance, In July 2020, Lonza Group AG has acquired a California facility from Shire plc. giving the Lonza drug developer another tool to grow its already lucrative mammalian manufacturing business. The facility is located in the San Francisco Bay Area, the 58,000-square-foot site adds 1,000 liter and 2,000 liter single-use bioreactors to Lonza’s arsenal, as well as associated downstream capabilities.
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis. It presents a 360-degree overview of the competitive landscape of the industries. The report provides qualitative and quantitative analysis of the market using various frameworks such as Porter’s and PESTLE analysis.
Dividing the Global Biologics Contract Manufacturing Market by Product types and Application
Based on type, the market has been segmented into:
MABs
Recombinant Protein
Others
Based on application, the market has been segmented into:
Oncology
Immunological Disorders
Cardiovascular Disorders (CVDs)
Hematological Disorders
Others
Why is the U.S. Biologics Contract Manufacturing Market Booming?
“Growing Wellness Initiatives to Raise Public Awareness”
In the market for biologics contract manufacturing in North America in 2023, the U.S. held a market share of about 89.9%. Strong biologics pipelines that are boosting demand for CMOs, high corporate venture capital investments that are advancing biotechnology R&D, and the establishment of important manufacturers and research institutions with specialised programmes for contract manufacturing organisations are all factors driving the growth of this market in U.S.
Following are major TOC of the Biologics Contract Manufacturing Market:
Chapter 1: Biologics Contract Manufacturing Market Overview
Chapter 2: Global Economic Impact on Industry
Chapter 3: Global Biologics Contract Manufacturing Market Competition by Manufacturers
Chapter 4: Global Production, Profits (Value) by Region
Chapter 5: Global Supply (Production), Import, Export, Consumption, by Regions
Chapter 6: Global Price Trend by Type, Revenue (Value), Production
Chapter 7: Manufacturing Cost Analysis
Chapter 8: Global Market Analysis by Application
Chapter 9: Industrial Chain and Downstream Buyers, Sourcing Strategy
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Global Biologics Contract Manufacturing Market Forecast
Keep it going ……
Our analysts examined the information and data and generated insights using a combination of quantitative and qualitative research efforts, with the primary purpose of delivering a holistic view of the market.
Reasons for buying this report:
– Biologics Contract Manufacturing Market segmentation analysis includes qualitative and quantitative research incorporating the impact of economic and non-economic aspects.
– Analysing the outlook of the Biologics Contract Manufacturing market with the recent trends and Porter’s five forces analysis
– To study current and future market outlook in the developed and emerging markets
– Market dynamics scenario, along with growth opportunities of the market in the years to come.
– Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategy employed by the major market players.
Customization Service of the Report:
The Global Biologics Contract Manufacturing Market report may well be modified to meet your detailed business essentials. Because we understand what our clients want, we provide up to 30% customization for any of our Market Intelligence Data reports at no added cost to all of our Users.
Please contact our sales experts ( sales@marketintelligencedata.com) and we will ensure that you get a report that suits your needs.
Thank you for taking the time to read our article…!!
About Us:
Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.
Contact Us:
Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA
Phone: +1 (704) 266-3234
Mail to: sales@marketintelligencedata.com
Xherald
